Inspire Investing’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SYRE
Inspire Investing's SYRE Position: Q3 2026 in Review
Inspire Investing opened a new position in Spyre Therapeutics (SYRE) in Q3 2026: 4,544 shares worth $405K. The stake represents 0.02% of the portfolio and ranks #1022 among its holdings.
286 funds tracked by Wall St. Rank hold SYRE as of Q3 2026.
- Inspire Investing held 4,544 shares of Spyre Therapeutics worth $405K as of Q3 2026.
- Spyre Therapeutics was a new Inspire Investing position in Q3 2026.
- Spyre Therapeutics made up 0.02% of Inspire Investing's portfolio in Q3 2026, its #1022 holding.
- 286 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q3 2026.
Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.